General description
PDMP closely resembles the natural sphingolipid substrate of brain glucosyltransferase and acts as a potent and competitive inhibitor of this enzyme. Blocks the outgrowth of neurites and inhibits glycolipid synthesis in cultured NIH/3T3 cells.
PDMP closely resembles the natural sphingolipid substrate of brain glucosyltransferase and is a potent and competitive inhibitor of this enzyme. Blocks the outgrowth of neurites and inhibits glycolipid synthesis in cultured 3T3 cells.
Packaging
50 mg in Plastic ampoule
Biochem/physiol Actions
Cell permeable: no
Primary Target
glycolipid synthesis in cultured NIH/3T3 cells
Product does not compete with ATP.
Reversible: no
Warning
Toxicity: Irritant (B)
Other Notes
Rani, C.S., et al. 1995. J. Biol. Chem. 270, 2859.
Rosenwald, A.G. 1992. Biochemistry31, 3581.
Inokuchi, J., and Radin, N.S. 1987. J. Lipid Res.28, 565.
Vunnam, R.R., and Radin, N.S. 1980. Chem. Phys. Lipids26, 265.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany